Mutations in the Kirsten rat sarcoma viral oncogene homologue (KRAS) are common in NSCLC, with the KRAS<sup>G12C</sup> variant accounting for approximately 40% of KRAS-mutant cases. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.